Santiago Coca

Santiago Coca

Auto-generated profile, based on publicly available information

Santiago Coca

Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, 28801 Alcalá de Henares, Spain

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
CGCielo García-Montero
Cielo García-Montero
ÓMÓscar Fraile Martínez
Óscar Fraile Martínez
AGAna M. Gómez-Lahoz
Ana M. Gómez-Lahoz
LPLeonel Pekarek
Leonel Pekarek
ACAlejandro J. Castellanos
Alejandro J. Castellanos
Miguel A. OrtegaMiguel A. Ortega
Miguel A. Ortega
The most prevalent diseases of our time, non-communicable diseases (NCDs) (including obesity, type 2 diabetes, cardiovascular diseases and some types of cancer) are rising worldwide. All of them share the condition of an “inflammatory disorder”, with impaired immune functions frequently caused or accompanied by alterations in gut microbiota. These multifactorial maladies also have in common malnutrition related to physiopathology. In this context, diet is the greatest modulator of immune system–microbiota crosstalk, and much interest, and new challenges, are arising in the area of precision nutrition as a way towards treatment and prevention. It is a fact that the westernized diet (WD) is partly responsible for the increased prevalence of NCDs, negatively affecting both gut microbiota and the immune system. Conversely, other nutritional approaches, such as Mediterranean diet (MD), positively influence immune system and gut microbiota, and is proposed not only as a potential tool in the clinical management of different disease conditions, but also for prevention and health promotion globally. Thus, the purpose of this review is to determine the regulatory role of nutritional components of WD and MD in the gut microbiota and immune system interplay, in order to understand, and create awareness of, the influence of diet over both key components.

9 March 2020 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
MOMiguel A. Ortega
Miguel A. Ortega
ÓMÓscar Fraile Martínez
Óscar Fraile Martínez
AAAngel Asúnsolo
Angel Asúnsolo
M. Julia BujánM. Julia Buján
M. Julia Buján
Natalio GArcia-HonduvillaNatalio GArcia-Honduvilla
Natalio GArcia-Honduvilla
SCSantiago Coca
Santiago Coca
Breast cancer is the cancer with the highest prevalence in women and is the number-one cause of cancer mortality worldwide. Cell transduction is a fundamental process in the development and progression of cancer. Modifications in various cell signalling pathways promote tumour cell proliferation, progression, and survival. The PI3K/Akt/mTOR pathway is an example of that, and it is involved in growth, proliferation, survival, motility, metabolism, and immune response regulation. Activation of this pathway is one of the main causes of cancer cell resistance to antitumour therapies. This makes PI3K/Akt/mTOR signalling a crucial object of study for understanding the development and progression of this disease. Thus, this pathway may have a role as a potential therapeutic target, as well as prognostic and diagnostic value, in patients with breast cancer. Despite the existence of selective PI3K/Akt/mTOR pathway inhibitors and current clinical trials, the cellular mechanisms are not yet known. The present review aims to understand the current state of this important disease and the paths that must be forged.

6 October 2021 in Polymers
Verified
Journal Article
Open access
PDF file
ÓMÓscar Fraile Martínez
Óscar Fraile Martínez
CGCielo García-Montero
Cielo García-Montero
ACAlejandro Coca
Alejandro Coca
Miguel Angel Alvarez-MonMiguel Angel Alvarez-Mon
Miguel Angel Alvarez-Mon
Jorge Monserrat SanzJorge Monserrat Sanz
Jorge Monserrat Sanz
Miguel A. OrtegaMiguel A. Ortega
Miguel A. Ortega
Polymer-based composites are a group of biomaterials that exert synergic and combined activity. There are multiple reported uses of these composites in multiple biomedical areas, such as drug carriers, in wound dressings, and, more prominently, in tissue engineering and regenerative medicine. Bone grafting is a promising field in the use of polymeric composites, as this is the second most frequently transplanted organ in the United States. Advances in novel biomaterials, such as polymeric composites, will undoubtedly be of great aid in bone tissue engineering and regeneration. In this paper, a general view of bone structure and polymeric composites will be given, discussing the potential role of these components in bone tissue. Moreover, the most relevant jawbone and maxillofacial applications of polymeric composites will be revised in this article, collecting the main knowledge about this topic and emphasizing the need of further clinical studies in humans.

28 August 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Miguel A. OrtegaMiguel A. Ortega
Miguel A. Ortega
ÓMÓscar Fraile Martínez
Óscar Fraile Martínez
Luis G GuijarroLuis G Guijarro
Luis G Guijarro
CCCarlos Casanova
Carlos Casanova
SCSantiago Coca
Santiago Coca
AAAngel Asúnsolo
Angel Asúnsolo
Breast cancer is the most prevalent and incident female neoplasm worldwide. Although survival rates have considerably improved, it is still the leading cause of cancer-related mortality in women. MicroRNAs are small non-coding RNA molecules that regulate the posttranscriptional expression of a wide variety of genes. Although it is usually located in the cytoplasm, several studies have detected a regulatory role of microRNAs in other cell compartments such as the nucleus or mitochondrion, known as “mitomiRs”. MitomiRs are essential modulators of mitochondrion tasks and their abnormal expression has been linked to the aetiology of several human diseases related to mitochondrial dysfunction, including breast cancer. This review aims to examine basic knowledge of the role of mitomiRs in breast cancer and discusses their prospects as biomarkers or therapeutic targets.

Verified
Journal Article
Open access
PDF file
Miguel A. OrtegaMiguel A. Ortega
Miguel A. Ortega
MGMiguel Ángel Sáez García
Miguel Ángel Sáez García
ÓMÓscar Fraile Martínez
Óscar Fraile Martínez
AAAngel Asúnsolo
Angel Asúnsolo
LPLeonel Pekarek
Leonel Pekarek
Natalio GArcia-HonduvillaNatalio GArcia-Honduvilla
Natalio GArcia-Honduvilla
Pregnancy is a period in a woman’s life associated with an increased risk of developing lower extremity chronic venous disease (CVD). Pregnancy-associated CVD is associated with changes in placental villi. We investigated angiogenesis and lymphangiogenesis in the placental villi of women with CVD during pregnancy compared with healthy controls with no history of CVD (HC). An observational, analytical, and prospective cohort study was conducted on 114 women in their third trimester of pregnancy (32 weeks). Sixty-two participants were clinically diagnosed with CVD. In parallel, 52 controls with no history of CVD (HC) were studied. Gene and protein expression of CD31, podoplanin (D2-40), Flt-1, and placental growth factor (PIGF) was analysed by real-time polymerase chain reaction (RT-qPCR) and immunohistochemistry. CD31 and D2-40 gene expression was significantly greater in the placental villi of women with CVD, as were the numbers of vessels positive for CD31 and D2-40. Significantly higher gene and protein expression of Flt-1 and PIGF was observed in the placental villi of women with CVD. Histological analysis showed more placental villi with periodic acid of Schiff (PAS)-positive material in women with CVD. Our results show a connection between pregnancy-associated CVD and leading to higher proangiogenic and lymphangiogenic activity in placental villi.

9 December 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MOMiguel A Ortega
Miguel A Ortega
MGMiguel Ángel Sáez García
Miguel Ángel Sáez García
AAAngel Asúnsolo
Angel Asúnsolo
BRBeatriz Romero
Beatriz Romero
CBCoral Bravo
Coral Bravo
Natalio GArcia-HonduvillaNatalio GArcia-Honduvilla
Natalio GArcia-Honduvilla
Pregnancy is a period in a woman’s life in which changes can occur that affect different physiological processes. Common conditions during this period include vascular changes, such as lower extremity venous insufficiency (VI). This is an observational, analytical, and prospective cohort study in which 114 pregnant women were analyzed, of which 62 were clinically diagnosed with VI. In parallel, 52 control patients without VI (HC) were studied. The aim of this study was to observe changes in angiogenesis and inflammation markers as well as the presence of calcium deposits. The expression of vascular endothelial growth factor (VEGF), transforming growth factor-β (TGF-β), and pigment epithelium-derived factor (PEDF) was analyzed by immunohistochemistry and RT-qPCR. The presence of calcium deposits was revealed using the von Kossa method. In the placentas of mothers with VI, gene expression of VEGF (34.575 [32.380–36.720] VI vs 32.965 [30.580–36.320] HC) and PEDF (25.417 [24.459–27.675] VI vs 24.400 [23.102–30.223] HC) significantly increased, as was protein expression in the placental villi. An increase in calcium deposits was observed in the placentas of women with VI (72.58% VI/53.84% HC). This study revealed the existence of cellular damage in the placental villi of mothers with VI with tissue implications such as increased calcification.